Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-12-11

Clinical Trial Update: Effects of Sitagliptin on Postprandial Lipemia in Men With Type 2 Diabetes [Phase 3]

View source ↗

Summary

This Phase 3 trial studied the effect of sitagliptin on postprandial lipemia in men with Type 2 Diabetes Mellitus; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sitagliptin (sitagliptin)

Snippet

Sponsor: Laval University | Conditions: Diabetes Mellitus, Postprandial Lipemia | Phase 3 | Status: COMPLETED | Results posted: 2012-12-11